Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome

Medical Science Monitor

Volumn 8, Issue 2, 2002, Pages

  Tesař, Vladimír ^a   Zima, Tomáš ^a   Jirsa Jr , Milan ^a   Crkovská, Jiřina ^a   Štípek, Stanislav ^a   Vernerová, Zdena ^a   Šeráková, Markéta ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adriamycin nephropathy; Eicosanoids; Lipoperoxidation; Malondialdehyde; Proteinuria

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; ENALAPRIL; FREE RADICAL; ICOSANOID; ISOPROSTANE DERIVATIVE; KININ DERIVATIVE; LOSARTAN; MALONALDEHYDE; PROSTAGLANDIN E2; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLOMERULUS; KIDNEY DISEASE; KIDNEY TUBULE PRESSURE; MEMBRANE PERMEABILITY; NEPHROTIC SYNDROME; NONHUMAN; OXIDATIVE STRESS; PROTEINURIA; RAT; URINARY EXCRETION;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DINOPROST; ENALAPRIL; F2-ISOPROSTANES; LOSARTAN; NEPHROTIC SYNDROME; RATS;

EID: 0036124364     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cellular injury by oxidants
2. Lipid peroxidation. An overview
3. Reactive oxygen species in living systems: Source, biochemistry and role in human disease
4. Non-cyclooxygenase - Derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids
5. The isoprostanes: Unique bioactive products of lipid peroxidation
6. Measurement of urinary 8-Epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers
7. 2 receptors
8. ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats
9. Angiotensin II receptor blockade, progression of nondiabetic-mediated renal disease
10. Free and bound malondialdehyde measured as thiobarbituric acid adduct by HPLC in serum and plasma
11. Stanovení produktu lipoperoxidace - Malondialdehydu - V biologickém materiálu spektrofotometricky a HPLC
12. Pharmacokinetics and metabolism of iodo-duxorubicin and doxorubicin in humans
13. Role of free radicals in cancerogenactivation
14. Suppressive effect of superoxide dismutase on adriumycin nephropathy
15. Effect of dietary protein restriction on renal purines and purine-metabolizing enzymes in adriamycin nephrosis in rats: A Mechanism for protection against acute proteinuria involving xanthine oxidase inhibition
16. Alpha-tocopherol reduces doxorubicin-induced toxicity in rats-histological and biochemical evidence
17. A role for oxygen radicals as second messengers
18. Reduction of urinary 8-epiprostaglandin F2 alpha during cyclooxygenase inhibition in rats but not in man
19. Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cydooxygenases
20. Angiotensin II inhibitors increase renal cortical cyclooxygenase-2 expression in rats on low salt diets
21. Stimulatory effect of 8-epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release
22. 2-isoprostane production and cytolysis in renal tubular epithelial cells
23. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome
24. Irreversible tubulo-interstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition
25. Effect of converting enzyme inhibition on the course of adriamycin-induced nephropathy
26. Pressor mechanisms in adriamycin-induced nephropathy with hypertension in rats
27. Tubulointerstitial injury and impaired renal function after recovery from acute puromycin nephrosis
28. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms
29. 1 angiotensin II receptors mediate increased intrarenal prostaglandin synthesis in hypercalcemic rats
30. Angiotensin II-stimulated nitric oxide release from endothelial cells is mediated by angiotensin IV